Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse Model-Reference-Cited by-同舟云学术

Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse Model

Published:2024-03-25 Issue:7 Volume:15 Page:1596-1608
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Sharma Sadhana¹,Risen Sydney²,Gilberto Vincenzo S.¹,Boland Sean²,Chatterjee Anushree¹,Moreno Julie A.²^ORCID,Nagpal Prashant¹^ORCID

Affiliation:

1. Sachi Bio, Colorado Technology Center, 685 S Arthur Avenue, Louisville, Colorado 80027, United States

2. Environmental & Radiological Health Sciences, and Brain Research Center, Colorado State University, Fort Collins, Colorado 80523, United States

Funder

Biological and Physical Sciences Division

Ames Research Center

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.4c00024

Reference55 articles.

1. National Multiple Sclerosis Society. How Many People Live with MS? https://www.nationalmssociety.org/What-is-MS/Who-Gets-MS/How-Many-People.

2. The prevalence of MS in the United States

3. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition

4. Multiple sclerosis prevalence in the United States commercially insured population

5. Risks and risk management in modern multiple sclerosis immunotherapeutic treatment

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model;ACS Pharmacology & Translational Science;2024-08-30

2. Inflammasome-Inhibiting Nanoligomers Are Neuroprotective against Space-Induced Pathology in Healthy and Diseased Three-Dimensional Human Motor and Prefrontal Cortex Brain Organoids;ACS Chemical Neuroscience;2024-07-31

3. Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy;Journal of Neuroinflammation;2024-07-27

4. Large- and Small-Animal Studies of Safety, Pharmacokinetics, and Biodistribution of Inflammasome-Targeting Nanoligomer in the Brain and Other Target Organs;ACS Pharmacology & Translational Science;2024-03-21

5. Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy;2024-02-07